EN
HI
Kabra Drugs Share price
KABRADG
28.05
0.46 (-1.61%)Last updated on 13 Jan, 2026 | 15:43 IST
BUYSELL
Today's High
29.80
Today's Low
28.00
52 Week Low
10.06
52 Week High
33.00
The current prices are delayed, login to your account for live prices
Login Kabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
26549.00
Market Cap
66.50 CR
LTQ@LTP
250@28.05
ATP
28.67
Var Margin
100 %
Circuit Range
27.09-29.93
Delivery %
0 %
Value
7.61 L
ASM/GSM
No
Market Lot
1
Summary
At 13 Jan, 2026 | 15:43, Kabra Drugs share price stands at ₹28.05, showing a 0.46% -1.61 for the day. The stock’s intraday movement has stayed between ₹28.00 and ₹29.80, while on a 52-week basis it has fluctuated from ₹10.06 to ₹33.00.
In terms of trading activity, Kabra Drugs has recorded a volume of 26549 shares, with a market capitalisation of ₹23707850. The stock’s Average Traded Price (ATP) stands at ₹2867, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 250,2805. The stock operates within a circuit range of ₹27.09-29.93, with a Value of ₹7.61 L. The Delivery Percentage for the day is %. Additionally, Kabra Drugs currently falls under the No framework, and trades with a market lot size of 1.
Kabra Drugs Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.98
Sector P/B
0.94
Sec. Div. Yield
0.57
Kabra Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-28 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-10-08 | Others |
| 2025-09-02 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-08-06 | Others |
| 2025-06-18 | Others |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Kabra Drugs News
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
Kabra Drugs Similar Stocks
Broach Lifecare Hospital Ltd.
13.11
0.00 (0.00%)
Unjha Formulations Ltd.
22.97
-1.03 (4.29%)
Cian Healthcare Ltd.
5.09
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
6.53
-0.34 (4.95%)
Gian Life Care Ltd.
10.28
0.16 (1.58%)
Decipher Labs Ltd.
8.20
-0.82 (9.09%)
Dhanvantri Jeevan Rekha Ltd.
23.32
-1.22 (4.97%)
Dr Lalchandani Labs Ltd.
23.69
0.00 (0.00%)
Transpact Enterprises Ltd.
137.25
0.00 (0.00%)
MPS Pharmaa Ltd.
1.68
0.00 (0.00%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 28.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Kabra Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 69.98 & 0.94 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 66.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 33.00 & 10.06. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Kabra Drugs belongs to the Healthcare sector.